痤瘡治療藥物市場規模、佔有率和成長分析（按產品、類型、給藥途徑、年齡層、配銷通路和地區）- 2025-2032 年行業預測

痤瘡治療市場預計將在 2023 年達到 111 億美元，從 2024 年的 120.3 億美元成長到 2032 年的 229.4 億美元，預測期內（2025-2032 年）的複合年成長率為 8.4%。

痤瘡仍然是全球最常見的皮膚病之一，影響著不同年齡層的數百萬人，對有效治療的需求龐大。人們對皮膚健康、外觀和自我護理意識的增強導致人們對痤瘡藥物的興趣增加。皮膚病學領域的不斷研究和開發帶來了創新有效的藥物，包括先進的外用、口服和聯合治療。此外，壓力、飲食選擇和污染等現代生活方式因素與痤瘡的關係越來越密切，越來越多的人尋求針對這些皮膚問題的針對性解決方案。隨著人們對痤瘡及其對生活方式的影響的認知不斷提高，痤瘡藥物市場不斷擴大，優先為消費者提供有效、客製化的治療方案。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步
• 貿易分析
• 客戶和購買標準分析

痤瘡治療市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 外用類視色素
• 口服抗生素
• 口服類視色素
• 場外交易（OTC）
• 異維他命A酸
• 其他

痤瘡治療藥物市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 發炎性痤瘡
• 非發炎性痤瘡

痤瘡治療市場規模（按給藥途徑和複合年成長率） (2025-2032)

• 市場概況
• 局部的
• 口服
• 注射

痤瘡治療市場規模（按年齡層別分類）及複合年成長率（2025-2032 年）

• 市場概況
• 10 至 17 歲
• 18 至 44 歲
• 45 至 64 歲
• 年齡 65 歲或以上

痤瘡治療藥物市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 醫院藥房
• 零售藥局
• 網路藥局
• 其他

痤瘡治療市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Johnson & Johnson Services, Inc.（USA）
• GlaxoSmithKline plc（GSK）（United Kingdom）
• Pfizer Inc.（USA）
• AbbVie Inc.（USA）
• Sun Pharmaceutical Industries Ltd.（India）
• Bausch Health Companies Inc.（Canada）
• Nestle Skin Health SA（Switzerland）
• Bayer AG（Germany）
• Viatris Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• F. Hoffmann-La Roche Ltd（Switzerland）
• LEO Pharma A/S（Denmark）
• Mylan NV（USA）
• Mayne Pharma Group Limited（Australia）
• Zydus Lifesciences Limited（India）
• Crown Laboratories（USA）
• Stryke Club（USA）

結論和建議

Acne Medication Market size was valued at USD 11.1 billion in 2023 and is poised to grow from USD 12.03 billion in 2024 to USD 22.94 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

Acne remains one of the most prevalent skin conditions worldwide, impacting millions across various age groups and driving significant demand for effective treatments. Growing awareness of skin health, appearance, and self-care is fueling interest in acne solutions. Continuous research and development in dermatology have resulted in innovative and effective medications, including advanced topical and oral treatments, as well as combination therapies. Additionally, modern lifestyle factors such as stress, dietary choices, and pollution are increasingly associated with acne, prompting individuals to seek targeted solutions for these skin concerns. As awareness and lifestyle impacts converge, the market for acne medication continues to expand, prioritizing effective and tailored treatment options for consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Medication market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Medication Market Segments Analysis

Global Acne Medication Market is segmented by Product, Type, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Topical Retinoids, Oral Antibiotics, Oral Retinoids, Over-the-Counter (OTC) Drugs, Isotretinoin and Others. Based on Type, the market is segmented into Inflammatory Acne and Non-inflammatory Acne. Based on Route of Administration, the market is segmented into Topical, Oral and Injectable. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Medication Market

The rising need for effective acne treatment options has led to the launch of numerous products tailored to address this issue, such as retinoids, isotretinoins, and both oral and topical antibiotics. These diverse offerings have significantly contributed to increasing global awareness regarding acne treatments and the various products available to manage it. This heightened awareness, in turn, has been instrumental in driving the growth of the acne medication market, as more individuals seek solutions for their skin concerns. As a result, the market is expanding rapidly, catering to the increasing demand for effective acne care solutions.

Restraints in the Acne Medication Market

Although chronic acne is a widespread issue globally, the expansion of the acne medication market faces several challenges. A significant hurdle is the side effects linked to various acne treatment medications. Research by the National Center for Biotechnology Information (NCBI) indicates that around 7% of individuals using tetracycline and 4% of those on macrolides report adverse effects, including nausea, vomiting, and diarrhea. These reactions can deter patients from seeking treatment and adhering to prescribed regimens, ultimately restraining the market's growth potential and limiting the effectiveness of available therapeutic options.

Market Trends of the Acne Medication Market

The global acne medication market is witnessing robust expansion, propelled by a surge in awareness regarding skincare and rising acne prevalence among teenagers and adults alike. Factors such as hormonal fluctuations and lifestyle choices-characterized by increased stress and dietary changes-are contributing to acne incidences. Furthermore, the growing trend of proactive skincare regimes among consumers is driving the adoption of specialized acne treatments, including topical solutions and oral medications. Innovations in formulation, including natural and cruelty-free products, are also aligning with consumer preferences, bolstering market penetration. As a result, the acne medication market is projected to sustain its upward trajectory in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement
• Trade Analysis
• Customer & Buying Criteria Analysis

Global Acne Medication Market Size by Product & CAGR (2025-2032)

• Market Overview
• Topical Retinoids
• Oral Antibiotics
• Oral Retinoids
• Over-the-Counter (OTC) Drugs
• Isotretinoin
• Others

Global Acne Medication Market Size by Type & CAGR (2025-2032)

• Market Overview
• Inflammatory Acne
• Non-inflammatory Acne

Global Acne Medication Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Topical
• Oral
• Injectable

Global Acne Medication Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 10 to 17 Years
• 18 to 44 Years
• 45 to 64 Years
• 65 Years & Above

Global Acne Medication Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Acne Medication Market Size & CAGR (2025-2032)

• North America (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Skin Health S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LEO Pharma A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayne Pharma Group Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryke Club (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations